These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Critical appraisal of inflammatory markers in cardiovascular risk stratification. Krintus M; Kozinski M; Kubica J; Sypniewska G Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900 [TBL] [Abstract][Full Text] [Related]
4. Novel Biomarkers of Heart Failure. Savic-Radojevic A; Pljesa-Ercegovac M; Matic M; Simic D; Radovanovic S; Simic T Adv Clin Chem; 2017; 79():93-152. PubMed ID: 28212715 [TBL] [Abstract][Full Text] [Related]
5. Novel biomarkers for cardiovascular risk prediction. Wang J; Tan GJ; Han LN; Bai YY; He M; Liu HB J Geriatr Cardiol; 2017 Feb; 14(2):135-150. PubMed ID: 28491088 [TBL] [Abstract][Full Text] [Related]
6. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP. Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice. Parikh SV; de Lemos JA Am J Med Sci; 2006 Oct; 332(4):186-97. PubMed ID: 17031244 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department. Bahrmann P; Christ M; Hofner B; Bahrmann A; Achenbach S; Sieber CC; Bertsch T Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):568-578. PubMed ID: 26483565 [TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531 [TBL] [Abstract][Full Text] [Related]
10. Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome. Katsioupa M; Kourampi I; Oikonomou E; Tsigkou V; Theofilis P; Charalambous G; Marinos G; Gialamas I; Zisimos K; Anastasiou A; Katsianos E; Kalogeras K; Katsarou O; Vavuranakis M; Siasos G; Tousoulis D Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895374 [TBL] [Abstract][Full Text] [Related]
11. Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease. Rubini Gimenez M; Twerenbold R; Mueller C Expert Rev Mol Diagn; 2015 Apr; 15(4):547-56. PubMed ID: 25676700 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Shlipak MG; Ix JH; Bibbins-Domingo K; Lin F; Whooley MA Am J Med; 2008 Jan; 121(1):50-7. PubMed ID: 18187073 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836 [TBL] [Abstract][Full Text] [Related]
14. The role of cardiac biomarkers in cardiovascular disease risk assessment. Collinson P Curr Opin Cardiol; 2014 Jul; 29(4):366-71. PubMed ID: 24848409 [TBL] [Abstract][Full Text] [Related]
16. Identifying new Risk Markers and Potential Targets: The Value of the Proteome. Kontush A Cardiovasc Drugs Ther; 2016 Feb; 30(1):13-8. PubMed ID: 26931819 [TBL] [Abstract][Full Text] [Related]
17. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. Jackson CE; Haig C; Welsh P; Dalzell JR; Tsorlalis IK; McConnachie A; Preiss D; Anker SD; Sattar N; Petrie MC; Gardner RS; McMurray JJ Eur J Heart Fail; 2016 Dec; 18(12):1491-1498. PubMed ID: 27114189 [TBL] [Abstract][Full Text] [Related]
18. Utility of Cardiac Biomarkers in the Setting of Kidney Disease. Savoj J; Becerra B; Kim JK; Fusaro M; Gallieni M; Lombardo D; Lau WL Nephron; 2019; 141(4):227-235. PubMed ID: 30726855 [TBL] [Abstract][Full Text] [Related]